Human clinical trials could begin as early as next year
A team of researchers at the University of Georgia’s Regenerative Bioscience Center and ArunA Biomedical, a UGA startup company, have developed a new treatment for stroke that reduces brain damage and accelerates the brain’s natural healing tendencies in animal models. They published their findings in the journal Translational Stroke Research.
The research team led by UGA professor Steven Stice and Nasrul Hoda of Augusta University created a treatment called AB126 using extracellular vesicles (EV), fluid-filled structures known as exosomes, which are generated from human neural stem cells.
Fully able to cloak itself within the bloodstream, this type of regenerative EV therapy appears to be the most promising in overcoming the limitations of many cell therapies—with the ability for exosomes to carry and deliver multiple doses—as well as the ability to store and administer treatment. Small in size, the tiny tubular shape of an exosome allows EV therapy to cross barriers that cells cannot.
“This is truly exciting evidence, because exosomes provide a stealth-like characteristic, invisible even to the body’s own defenses,” said Stice, Georgia Research Alliance Eminent Scholar and D.W. Brooks Distinguished Professor in the College of Agricultural and Environmental Sciences. “When packaged with therapeutics, these treatments can actually change cell progression and improve functional recovery.”
Following the administration of AB126, the researchers used MRI scans to measure brain atrophy rates in preclinical, age-matched stroke models, which showed an approximately 35 percent decrease in the size of injury and 50 percent reduction in brain tissue loss—something not observed acutely in previous studies of exosome treatment for stroke.
Outside of rodents, the results were replicated by Franklin West, associate professor of animal and dairy science, and fellow RBC members using a porcine model of stroke—the only one of its kind in the U.S.
Based on these pre-clinical results, ArunA Biomedical plans to begin human studies in 2019, said Stice, who is also chief scientific officer of ArunA Biomedical.
“Until now, we had very little evidence specific to neural exosome treatment and the ability to improve motor function,” said Stice. “Just days after stroke, we saw better mobility, improved balance and measurable behavioral benefits in treated animal models.”
Named as part of the ‘stroke belt’ region, Georgia continues to exceed the national average in stroke deaths, which is the third leading cause of death in the U.S., with more than 140,000 Americans dying each year, according to the Centers for Disease Control and Prevention.
ArunA recently unveiled advances to the company’s proprietary neural cell platform for the production of exosome manufacturing. Today, ArunA’s manufacturing process positions the company to produce AB126 exosomes at a scale to meet early clinical demand. The company has plans to expand this initiative beyond stroke for preclinical studies in epilepsy, traumatic brain and spinal cord injuries later this year.
The Latest on: Stroke treatment
Boone Hospital Center awarded for stroke treatment
on May 23, 2018 at 10:51 am
The American Heart Association and American Stroke Association have awarded Boone Hospital Center with their Get With The Guidelines-Stroke Gold Plus Quality Achievement Award. The award is the highest level offered by the associations, recognizing ... […]
UC Awarded $29 Million to Study tPA Combination Therapy in Stroke Treatment
on May 23, 2018 at 8:42 am
A nearly $30 million grant from the National Institutes of Health (NIH) will fund research led by the University of Cincinnati (UC) College of Medicine’s Department of Emergency Medicine to examine the effectiveness of combination therapies implementing ... […]
Stroke researchers confirm role of frontal lesions in response to prism treatment
on May 22, 2018 at 5:11 pm
Stroke researchers have confirmed that the presence of frontal cortical lesions moderated response to prism adaptation treatment after right-brain stroke. Their findings are detailed in "Frontal lesions predict response to prism adaptation treatment in ... […]
Bioengineered gel heals the brains of stroke-injured mice, paves way for human treatment
on May 22, 2018 at 10:38 am
Researchers from the University of California – Los Angeles (UCLA) have developed a gel that helped stroke-damaged brains of rats heal. Brains have a limited capacity for recovery after damage or disease. They don’t regrow blood vessels, can’t ... […]
DAWN of a New Day: New Treatment Insights Shared at Atlantic Health's 18th Annual 'Stroke Symposium'
on May 21, 2018 at 7:41 pm
MORRISTOWN, NJ - Time is of the essence when it comes to identifying and treating symptoms of stroke and it’s widely accepted that the sooner treatment is provided the better the outcome will be, however new research suggests that all hope isn’t lost ... […]
CT scan still effective to determine thrombectomy treatment in stroke, study shows
on May 20, 2018 at 11:54 pm
A study led by a neurologist from McGovern Medical School at The University of Texas Health Science Center at Houston (UTHealth) showed that a computed tomography (CT scan) could be sufficient for determining thrombectomy treatment in stroke. The late ... […]
Speedy treatment is of the essence to counteract a stroke
on May 18, 2018 at 7:39 pm
I was reading a story in the St Cloud paper last week about a relatively healthy 64-year-old Minnesota farmer who had a stroke, was rushed to the hospital, and is on the way to a complete recovery. He had spoken out because May is American Stroke Month and ... […]
Quick recognition, treatment help Maine stroke survivor recover in hours
on May 17, 2018 at 7:38 am
Before her pre-dawn runs, Sarah Belliveau likes fueling herself with a cup of coffee. The morning of June 15, 2017, she couldn’t. She forgot how. “I remember looking at the machine and knowing I needed to push the button,” she said, “but there was ... […]
New treatment option for 'wake-up' stroke patients
on May 16, 2018 at 5:50 am
Detail revealed in MRI brain scans can help doctors accurately deduce when a stroke begins, according to new research, allowing treatment for many patients who currently cannot receive it. The findings could help to better treat stroke patients ... […]
via Google News and Bing News